New study aims to scale up opioid addiction treatment to curb HIV in central asia

NCT ID NCT05579470

First seen Oct 31, 2025 · Last updated May 03, 2026 · Updated 24 times

Summary

This study aims to expand medication-assisted treatment (MAT) for opioid use disorder in Kazakhstan, Kyrgyzstan, and Tajikistan. By increasing access to MAT, researchers hope to reduce HIV infections among people who inject drugs and their partners. The study involves 900 participants and focuses on improving treatment programs through collaboration and training.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Columbia University Global Health Research Center of Central Asia

    RECRUITING

    Almaty, Kazakhstan

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Den Sooluk Nuru

    RECRUITING

    Bishkek, Kyrgyzstan

    Contact Email: •••••@•••••

    Contact

  • Institute for International Health and Education

    RECRUITING

    Dushanbe, Tajikistan

    Contact Email: •••••@•••••

    Contact

  • Yale University

    ACTIVE_NOT_RECRUITING

    New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.